TrialNeuro-oncology2022

Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.

Wenya Linda Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.